Professor Yury Gogotsi , Drexel University, USA, received an Honorary Doctorate from Frantsevich Institute for Problems of Materials Science, National Academy of Science of Ukraine.
Deputy Directors of IPMS NAS professors Dr. Firstov, Dr. Ragulya, Dr. Baglyuk, and Mr. Zavorotnyi and Scientific Secretary Dr. Kartuzov participated in the ceremony. This is just the fifth Honorary Doctor of IPMS NAS certificate issued in the history of the Frantsevich Institute for Problems of Materials Science, NASU.
Last position of Yury Gogotsi in Ukraine, before his Humboldt Fellowship, was at this institute. He also received his Dr. Sci. Degree in Materials Engineering from this institute. It used to be the leading materials science research center in the former Soviet Union.
Institute for Problems in Materials Science (IPMS) is Ukrainian leading centre of advanced scientific and engineering services, technical consulting and contract research and development in the field of Material science and advanced technology of metal, ceramic and composite materials IPMS was set up in 1955 on the base of the laboratory for special alloys of the Ukrainian Academy of Sciences. Since then it has progressively widened its fields of application and customer base. IPMS has no analogues among academic institutions due a great variety of new developments in technological processes, materials and products on their base.. IPMS employs about 1700 people, including 70 doctors and more than 345 Ph.D., among them Members of Ukrainian Academy of Sciences, professors.
IPMS is a large scientific and research complex, including Special Design Bureau with Pilot Plants, Computer Centre and Laboratory for Basalt Materials Production. All achievements in the development of new materials with their further commercial application are supported by wide basic researches in the field of solid-state physics and chemistry, inorganic physical chemistry, mechanics of deformable media. IPMS' scientists are expanding the national activity collaborating with different companies from the U.S.A., United Kingdom, France, Germany, Yugoslavia, Poland, Hungary, Bulgaria, Austria, Switzerland, Mexico, India, Cuba, South Korea, Israel, Japan, China etc. IPMS sells licenses on the advanced technologies as, well as set up Joint Ventures for the production of cutting tools, wear and corrosion resistant coatings using detonation spraying technique, ceramics for electrical application, ceramic powders of high purity. Institute has set up service centres operating on the base of the detonation coating technology in Japan, China, Yugoslavia, Iran.
Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
Congratulations to all collaborators with this interesting joint work!
Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field. 
Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
Here we demonstrate a new developed method for depositing Ti3C2Tx MXenes onto hydrophobic electrospun PCL membranes using oxygen plasma treatment. These novel patches hold tremendous potential for providing mechanical support to damaged heart tissue and enabling electrical signal transmission,thereby mimicking the crucial electroconductivity required for normal cardiac function. After a detailed investigation of scaffold-to-cell interplay, including electrical stimulation, novel technology has the potential for clinical application not only for cardiac regeneration, but also as neural and muscular tissue substitutes.
MX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications. 
CanbioSe Project Meeting and Project Workshop was held at European Institute of Membranes (IEM), University of Montpellier, France on September 26-27, 2023. The workshop was focused on the theme of "Commercializing Biosensors, Intellectual Property, and Knowledge Transfer from Academia to Industry.
Dr. Oleksiy Gogotsi and Veronika Zahorodna visited IEEE NAP 2023 conference held in Bratislava on September 10-15, 2023. The prime focus of the IEEE NAP-2023 was on nanoscale materials with emphasis on interdisciplinary research exploring and exploiting their unique physical and chemical proprieties for practical applications.
Director of MRC and Carbon-Ukraine Dr. Oleksiy Gogotsi visited CEST labs in Wiener Neustadt (Low Energy Ion Scattering, Batteries development) and TU Vienna (ELSA, SFA). He meet with Dr. Pierluigi Bilotto, Dr. Chriatian Pichler and their colleagues, discussing novel materials and r&d activities for new technologies.